OMER: Omeros Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 424.45
Enterprise Value ($M) 824.89
Book Value ($M) -182.61
Book Value / Share -3.14
Price / Book -2.32
NCAV ($M) -325.57
NCAV / Share -5.61
Price / NCAV -1.30

Profitability (mra)
Return on Invested Capital (ROIC) -0.65
Return on Assets (ROA) -0.36
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.69
Current Ratio 1.69

Balance Sheet (mrq) ($M)
Current Assets 134.12
Assets 277.08
Liabilities 459.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -169.26
Net Income -156.81
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -148.80
Cash from Investing 82.22
Cash from Financing 62.88

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-21 13G/A Ingalls & Snyder Llc 7.20 -6.09

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-28 41,631 210,183 19.81
2025-04-25 37,909 318,898 11.89
2025-04-24 47,443 289,624 16.38
2025-04-23 79,153 624,707 12.67

(click for more detail)

Similar Companies
OCS – Oculis Holding AG OCUL – Ocular Therapeutix, Inc.
OKUR – OnKure Therapeutics, Inc. PAHC – Phibro Animal Health Corporation
PTGX – Protagonist Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Omeros Corporation